Caricamento...
New-Onset Diabetes Mellitus With Exposure to Ledipasvir and Sofosbuvir
The combination therapy of ledipasvir/sofosbuvir was approved by the Food and Drug Administration in 2014 for the treatment of chronic hepatitis C. Although hyperglycemia is not well known to occur with its use, we present 2 cases of new-onset diabetes mellitus and a review of the literature suggest...
Salvato in:
| Pubblicato in: | J Investig Med High Impact Case Rep |
|---|---|
| Autori principali: | , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
SAGE Publications
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710113/ https://ncbi.nlm.nih.gov/pubmed/26788529 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2324709615623300 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|